JP2009541387A5 - - Google Patents

Download PDF

Info

Publication number
JP2009541387A5
JP2009541387A5 JP2009516965A JP2009516965A JP2009541387A5 JP 2009541387 A5 JP2009541387 A5 JP 2009541387A5 JP 2009516965 A JP2009516965 A JP 2009516965A JP 2009516965 A JP2009516965 A JP 2009516965A JP 2009541387 A5 JP2009541387 A5 JP 2009541387A5
Authority
JP
Japan
Prior art keywords
alkyl
compound according
membered heteroaryl
phenyl
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009516965A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009541387A (ja
JP4944954B2 (ja
Filing date
Publication date
Priority claimed from GBGB0612630.4A external-priority patent/GB0612630D0/en
Application filed filed Critical
Publication of JP2009541387A publication Critical patent/JP2009541387A/ja
Publication of JP2009541387A5 publication Critical patent/JP2009541387A5/ja
Application granted granted Critical
Publication of JP4944954B2 publication Critical patent/JP4944954B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009516965A 2006-06-26 2007-06-25 ホスファチジルイノシトール３−キナーゼ阻害剤としてのチアゾリルウレア誘導体 Expired - Fee Related JP4944954B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0612630.4 2006-06-26
GBGB0612630.4A GB0612630D0 (en) 2006-06-26 2006-06-26 Organic compounds
PCT/EP2007/005599 WO2008000421A2 (en) 2006-06-26 2007-06-25 Thiazolyl urea derivatives as phosphatidylinositol 3-kinase inhibitors

Publications (3)

Publication Number Publication Date
JP2009541387A JP2009541387A (ja) 2009-11-26
JP2009541387A5 true JP2009541387A5 (enExample) 2012-03-08
JP4944954B2 JP4944954B2 (ja) 2012-06-06

Family

ID=36803903

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009516965A Expired - Fee Related JP4944954B2 (ja) 2006-06-26 2007-06-25 ホスファチジルイノシトール３−キナーゼ阻害剤としてのチアゾリルウレア誘導体

Country Status (12)

Country Link
US (1) US7799810B2 (enExample)
EP (1) EP2035413A2 (enExample)
JP (1) JP4944954B2 (enExample)
KR (1) KR20090024294A (enExample)
CN (1) CN101479258A (enExample)
AU (1) AU2007264033A1 (enExample)
BR (1) BRPI0713784A2 (enExample)
CA (1) CA2655568A1 (enExample)
GB (1) GB0612630D0 (enExample)
MX (1) MX2008016358A (enExample)
RU (1) RU2009102270A (enExample)
WO (1) WO2008000421A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0725888B2 (ja) 1986-09-17 1995-03-22 旭化成工業株式会社 エ−テルチオエ−テル−芳香族スルホン系共重合体及びその製造方法
RU2011111728A (ru) 2008-08-29 2012-10-10 Топотаргет А/С (Dk) Новые производные мочевины и тиомочевины
UA104147C2 (uk) * 2008-09-10 2014-01-10 Новартис Аг Похідна піролідиндикарбонової кислоти та її застосування у лікуванні проліферативних захворювань
WO2010065923A2 (en) * 2008-12-04 2010-06-10 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Phosphatidylinositol-3-kinase p110 delta-targeted drugs in the treatment of cns disorders
JPWO2010092962A1 (ja) 2009-02-12 2012-08-16 アステラス製薬株式会社 へテロ環誘導体
EP2492269A4 (en) 2009-10-19 2013-08-07 Taisho Pharmaceutical Co Ltd aminothiazole
EP2604601B1 (en) 2010-08-10 2016-02-24 Astellas Pharma Inc. Hetero ring compound
CN107899012A (zh) 2011-01-11 2018-04-13 戴麦里克斯生物科学有限公司 联合疗法
EP2790705B1 (en) 2011-12-15 2017-12-06 Novartis AG Use of inhibitors of the activity or function of pi3k
WO2015055691A1 (en) * 2013-10-17 2015-04-23 Glaxosmithkline Intellectual Property Development Limited Pi3k inhibitor for treatment of respiratory disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR038703A1 (es) * 2002-02-28 2005-01-26 Novartis Ag Derivados de 5-feniltiazol y uso como inhibidor de quinasa p i 3
AR044519A1 (es) 2003-05-02 2005-09-14 Novartis Ag Derivados de piridin-tiazol amina y de pirimidin-tiazol amina
TWI334868B (en) * 2003-06-03 2010-12-21 Nippon Kayaku Kk [1,2,4] triazoro [1,5-a] pyrimidine-2-ylurea derivative and use thereof
GB0320197D0 (en) 2003-08-28 2003-10-01 Novartis Ag Organic compounds
GB0423653D0 (en) 2004-10-25 2004-11-24 Piramed Ltd Pharmaceutical compounds

Similar Documents

Publication Publication Date Title
JP2009541387A5 (enExample)
JP2006524660A5 (enExample)
JP2018524390A5 (enExample)
JP2019509276A5 (enExample)
JP2010524932A5 (enExample)
SE0402735D0 (sv) Novel compounds
JP2010532386A5 (enExample)
NO20055892L (no) Karboksylsyrederivater
JP2007519649A5 (enExample)
JP2006509749A5 (enExample)
JP2017533930A5 (enExample)
JP2007507494A5 (enExample)
NO20071577L (no) Bifenyloksyiddiksyrederivater for behandling av luftveissykdommer
DE60206911D1 (de) Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren
JP2020097577A5 (enExample)
IL205501A (en) Preparation of preparations for the treatment of arthritis
JP2006501201A5 (enExample)
JP2019501879A5 (enExample)
NO20085271L (no) Muscarin reseptoragonister som er effektive i behandling av smerte, Alzheimers sykdom og schizofreni
JP2019505529A5 (enExample)
CN115315423A (zh) 取代芳基类化合物
SE0302573D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
EP4442321A3 (en) Methods of treating sjögren's syndrome using a bruton's tyrosine kinase inhibitor
MA46268B1 (fr) Dérivés de 5-[2-(pyridin-2-ylamino)-1 ,3-thiazol-5-yl]-2,3-dihydro-1h-isoindol-1-one et leur utilisation en tant qu'inhibiteurs doubles de phosphatidylinositol 3-kinase delta & gamma
JP2007515467A5 (enExample)